Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.12%) 5 333.75 points
Dow Jones Futures
(0.03%) 40 150 points
Nasdaq Futures
(0.20%) 18 672 points
Oil
(-0.41%) $79.73
Gas
(0.61%) $2.64
Gold
(1.20%) $2 446.50
Silver
(3.46%) $32.34
Platinum
(0.30%) $1 093.30
USD/EUR
(0.01%) $0.920
USD/NOK
(-0.06%) $10.67
USD/GBP
(0.03%) $0.787
USD/RUB
(-0.41%) $90.60

Realtime updates for Ardelyx Inc [ARDX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
64.86%
return 16.08%
SELL
27.03%
return 23.10%
Last Updated17 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

0.26% $ 7.81

BUY 15525 min ago

@ $8.30

Issued: 9 May 2024 @ 11:25

Return: -5.85%

Previous signal: May 9 - 10:39

Previous signal: Sell

Return: -1.45 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally...

Stats
Today's Volume 2.29M
Average Volume 5.78M
Market Cap 1.83B
EPS $0 ( 2024-05-02 )
Next earnings date ( $0 ) 2024-07-31
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -27.89
ATR14 $0.00900 (0.12%)
Insider Trading
Date Person Action Amount type
2024-05-14 Raab Michael Sell 3 000 Common Stock
2024-05-06 Felsch Robert Ora Buy 40 000 Common Stock
2024-05-06 Felsch Robert Ora Buy 79 101 Common Stock
2024-05-06 Felsch Robert Ora Sell 152 988 Common Stock
2024-05-06 Felsch Robert Ora Sell 55 000 Common Stock
INSIDER POWER
37.26
Last 99 transactions
Buy: 4 225 912 | Sell: 1 795 207

Volume Correlation

Long: 0.36 (neutral)
Short: -0.29 (neutral)
Signal:(59.242) Neutral

Ardelyx Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ardelyx Inc Correlation - Currency/Commodity

The country flag 0.18
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.68
( moderate )
The country flag 0.00
( neutral )
The country flag -0.23
( neutral )

Ardelyx Inc Financials

Annual 2023
Revenue: $124.46M
Gross Profit: $106.66M (85.70 %)
EPS: $-0.300
FY 2023
Revenue: $124.46M
Gross Profit: $106.66M (85.70 %)
EPS: $-0.300
FY 2022
Revenue: $52.16M
Gross Profit: $48.04M (92.11 %)
EPS: $-0.420
FY 2021
Revenue: $10.10M
Gross Profit: $9.10M (90.10 %)
EPS: $-1.520

Financial Reports:

No articles found.

Ardelyx Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ardelyx Inc

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators